326 related articles for article (PubMed ID: 14578681)
21. Radiopharmaceutical pharmacokinetics in animals: critical considerations.
Giron MC
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):359-64. PubMed ID: 19834444
[TBL] [Abstract][Full Text] [Related]
22. Applications of positron-emitting halogens in PET oncology (Review).
Glaser M; Luthra SK; Brady F
Int J Oncol; 2003 Feb; 22(2):253-67. PubMed ID: 12527920
[TBL] [Abstract][Full Text] [Related]
23. Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development.
Bergström M; Grahnén A; Långström B
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):357-66. PubMed ID: 12937873
[TBL] [Abstract][Full Text] [Related]
24. Bringing Radiotracing to Titanium-Based Antineoplastics: Solid Phase Radiosynthesis, PET and ex Vivo Evaluation of Antitumor Agent [(45)Ti](salan)Ti(dipic).
Severin GW; Nielsen CH; Jensen AI; Fonslet J; Kjær A; Zhuravlev F
J Med Chem; 2015 Sep; 58(18):7591-5. PubMed ID: 26312993
[TBL] [Abstract][Full Text] [Related]
25. Positron Emission Tomography: applications in drug discovery and drug development.
Wang J; Maurer L
Curr Top Med Chem; 2005; 5(11):1053-75. PubMed ID: 16181131
[TBL] [Abstract][Full Text] [Related]
26. (18)F Labeled benzimidazole derivatives as potential radiotracer for positron emission tomography (PET) tumor imaging.
Zhang S; Wang X; He Y; Ding R; Liu H; Xu J; Feng M; Li G; Wang M; Peng C; Qi C
Bioorg Med Chem; 2010 Apr; 18(7):2394-401. PubMed ID: 20303769
[TBL] [Abstract][Full Text] [Related]
27. [Positron emission tomography. A new measurement method for imaging of regional and biochemical parameters].
Bolwig TG; Haunsø S; Hove JD; Hesse B; Højgaard L; Jensen M; Paulson OB; Svendsen JH; Sørensen SS
Ugeskr Laeger; 1994 Oct; 156(43):6341-7. PubMed ID: 7810006
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of radiolabelled anticancer drugs for positron emission tomography.
Hutchinson OC; Collingridge DR; Barthel H; Price PM; Aboagye EO
Curr Pharm Des; 2003; 9(11):917-29. PubMed ID: 12678875
[TBL] [Abstract][Full Text] [Related]
29. Receptor imaging in oncology by means of nuclear medicine: current status.
Van Den Bossche B; Van de Wiele C
J Clin Oncol; 2004 Sep; 22(17):3593-607. PubMed ID: 15337810
[TBL] [Abstract][Full Text] [Related]
30. A shifting landscape: what will be next FDG in PET oncology?
Inoue T; Oriuchi N; Tomiyoshi K; Endo K
Ann Nucl Med; 2002 Feb; 16(1):1-9. PubMed ID: 11922202
[TBL] [Abstract][Full Text] [Related]
31. PET as a potential tool for imaging molecular mechanisms of oncology in man.
Price P
Trends Mol Med; 2001 Oct; 7(10):442-6. PubMed ID: 11597518
[TBL] [Abstract][Full Text] [Related]
32. PET and SPECT imaging of the opioid system: receptors, radioligands and avenues for drug discovery and development.
Lever JR
Curr Pharm Des; 2007; 13(1):33-49. PubMed ID: 17266587
[TBL] [Abstract][Full Text] [Related]
33. Use of positron emission tomography in animal research.
Cherry SR; Gambhir SS
ILAR J; 2001; 42(3):219-32. PubMed ID: 11406721
[TBL] [Abstract][Full Text] [Related]
34. Monitoring of treatment-induced apoptosis in oncology with PET and SPECT.
Blankenberg FG
Curr Pharm Des; 2008; 14(28):2974-82. PubMed ID: 18991713
[TBL] [Abstract][Full Text] [Related]
35. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
[TBL] [Abstract][Full Text] [Related]
36. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.
Dimitrakopoulou-Strauss A; Strauss L
Hell J Nucl Med; 2006; 9(1):10-21. PubMed ID: 16617388
[TBL] [Abstract][Full Text] [Related]
37. Use of positron emission tomography in anticancer drug development.
Aboagye EO; Price PM
Invest New Drugs; 2003 May; 21(2):169-81. PubMed ID: 12889738
[TBL] [Abstract][Full Text] [Related]
38. Positron emission tomography as an imaging biomarker.
Weber WA
J Clin Oncol; 2006 Jul; 24(20):3282-92. PubMed ID: 16829652
[TBL] [Abstract][Full Text] [Related]
39. Positron emission tomography in cancer research and treatment.
Mandelkern M; Raines J
Technol Cancer Res Treat; 2002 Dec; 1(6):423-39. PubMed ID: 12625770
[TBL] [Abstract][Full Text] [Related]
40. Positron emitting tracers in pre-clinical drug development.
Fernandes E; Barbosa Z; Clemente G; Alves F; Abrunhosa AJ
Curr Radiopharm; 2012 Apr; 5(2):90-8. PubMed ID: 22280107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
